| |
| |
|
| Insider
Information: |
Tahir Misbah |
| Relationship: |
|
| City: |
Mountain View |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
90,418 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
90,418 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Igm Biosciences, Inc. |
IGMS |
|
2024-03-14 |
90,418 |
2020-11-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IGMS |
Igm Biosciences, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2024-03-14 |
4 |
S |
$10.17 |
$25,864 |
D/D |
(2,543) |
90,418 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2024-03-13 |
4 |
S |
$9.88 |
$28,608 |
D/D |
(2,897) |
92,961 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
CHIEF FINANCIAL OFFICER |
• – – |
2024-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
46,250 |
95,858 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Chief Financial Officer |
• – – |
2023-11-27 |
4 |
S |
$5.06 |
$6,764 |
D/D |
(1,337) |
49,608 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Chief Financial Officer |
• – – |
2023-11-15 |
4 |
A |
$11.71 |
$2,740 |
D/D |
234 |
50,945 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Chief Financial Officer |
• – – |
2023-05-23 |
4 |
S |
$12.30 |
$15,497 |
D/D |
(1,259) |
50,711 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Chief Financial Officer |
• – – |
2023-05-15 |
4 |
A |
$11.71 |
$4,661 |
D/D |
398 |
51,970 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Chief Financial Officer |
• – – |
2023-04-04 |
4 |
A |
$0.00 |
$0 |
D/D |
26,250 |
51,572 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Chief Financial Officer |
• – – |
2023-03-14 |
4 |
S |
$18.73 |
$33,118 |
D/D |
(1,768) |
25,322 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Chief Financial Officer |
• – – |
2022-12-19 |
4 |
AS |
$20.00 |
$76,020 |
D/D |
(3,801) |
27,090 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Chief Financial Officer |
• – – |
2022-12-16 |
4 |
AS |
$18.77 |
$43,339 |
D/D |
(2,283) |
30,891 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Chief Financial Officer |
• – – |
2022-11-23 |
4 |
S |
$21.38 |
$18,918 |
D/D |
(877) |
33,174 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Chief Financial Officer |
• – – |
2022-11-15 |
4 |
A |
$12.84 |
$4,533 |
D/D |
353 |
34,051 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Chief Financial Officer |
• – – |
2022-05-26 |
4 |
S |
$17.10 |
$16,247 |
D/D |
(950) |
33,698 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Chief Financial Officer |
• – – |
2022-05-13 |
4 |
A |
$12.38 |
$4,841 |
D/D |
391 |
34,648 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Chief Financial Officer |
• – – |
2022-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
6,084 |
34,257 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Chief Financial Officer |
• – – |
2022-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
28,173 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Chief Financial Officer |
• – – |
2021-11-15 |
4 |
A |
$50.99 |
$4,385 |
D/D |
86 |
5,673 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Chief Financial Officer |
• – – |
2021-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
15,673 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Chief Financial Officer |
• – – |
2021-05-14 |
4 |
A |
$45.90 |
$2,066 |
D/D |
45 |
5,587 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Chief Financial Officer |
• – – |
2021-03-05 |
4 |
OE |
$1.39 |
$3,823 |
D/D |
2,750 |
5,542 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Chief Financial Officer |
• – – |
2020-12-21 |
4 |
OE |
$1.39 |
$3,823 |
D/D |
2,750 |
2,792 |
0 |
- |
|
| IGMS |
Igm Biosciences, Inc. |
Chief Financial Officer |
• – – |
2020-11-13 |
4 |
A |
$45.45 |
$1,909 |
D/D |
42 |
42 |
0 |
- |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
